ArticleJournal of personalized medicine2024

Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A "Real-Life" Observational Study.

Eugenio De Corso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.